MARATHON PATENT GROUP, INC. (NASDAQ:MARA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

to an agreement between the Company and each of the Company’s two (2) independent directors, on February 28, 2018, the Board approved and authorized the issuance of shares of the Company’s restricted common stock to such directors in lieu of cash fees earned as members of the Board during the quarter ended June 30, 2017, as follows: 9,150 shares to Chris Robichaud and 9,250 shares to Richard Chernicoff.

On February 23, 2018, subsequent to the resignation of the Manager and sole director of the Company’s subsidiaries, Marathon Group SA, Marathon Advisors S.a.r.l. and Marathon Ventures S.a.r.l. (the “Lux Subsidiaries”), the Board appointed Merrick D. Okamoto, the Company’s Interim Chief Executive Officer, to fill in the vacancies and serve as the Manager and sole director of each of the Lux Subsidiaries, effective immediately.

About MARATHON PATENT GROUP, INC. (NASDAQ:MARA)

Marathon Patent Group Inc. (MARA) is engaged in acquiring patents and patent rights from owners or other ventures. The Company monetizes its portfolio of patents and patent rights by entering into license discussions. The Company owns around 378 United States and foreign patents, and patent rights across a range of technologies and markets. The Company owns around 22 patent applications across a range of technologies and markets.